Ubiquitination-IN-1

CAS No. 1819330-15-8

Ubiquitination-IN-1( —— )

Catalog No. M26494 CAS No. 1819330-15-8

Ubiquitination-IN-1 is an inhibitor of ubiquitination and Cksl-Skp2 protein-protein interaction (IC50: 0.17 μM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 58 Get Quote
10MG 87 Get Quote
25MG 159 Get Quote
50MG 264 Get Quote
100MG 395 Get Quote
500MG 888 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Ubiquitination-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    Ubiquitination-IN-1 is an inhibitor of ubiquitination and Cksl-Skp2 protein-protein interaction (IC50: 0.17 μM).
  • Description
    Ubiquitination-IN-1 is an inhibitor of ubiquitination and Cksl-Skp2 protein-protein interaction (IC50: 0.17 μM).(In Vitro):Ubiquitination-IN-1 inhibits A549 and HT1080 cells (IC50s: 0.91 and 0.4 μM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Pim2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1819330-15-8
  • Formula Weight
    429.42
  • Molecular Formula
    C21H14F3N3O2S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 83.33 mg/mL (194.06 mM)
  • SMILES
    FC(F)(F)c1cccc(c1)S(=O)(=O)Nc1ccc(-c2cccnc2)c2cccnc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Zhao YQ, Yin YQ, Liu J, Wang GH, Huang J, Zhu LJ, Wang JH. Characterization of HJ-PI01 as a novel Pim-2 inhibitor that induces apoptosis and autophagic cell death in triple-negative human breast cancer. Acta Pharmacol Sin. 2016 Sep;37(9):1237-50.
molnova catalog
related products
  • Oxytroflavoside D

    The branches of Magnolia utilis.

  • Syk Inhibitor II hyd...

    The impact of spleen tyrosine kinase (Syk) signaling might be prominent in lupus because (i) Syk is a shared downstream signaling molecule among circulating immune complex, LPS, and (1→3)-β-D-glucan (BG), and (ii) all of these factors are detectable in the serum of Fc gamma receptor IIb-deficient (FcgRIIb-/-) mice with sepsis. Syk inhibition downregulated several inflammatory pathways in FcgRIIb-/- macrophages activated with BG + LPS suggesting the potential anti-inflammatory impact of Syk inhibitors in lupus.

  • Naringenin triacetat...

    Naringenin triacetate exhibits a better binding affinity with multiple crystal structures of first bromodomain BRD4 (BRD4 BD1) when compared with the known inhibitors.